We are live on ! Find out more
HCA

Harbor Capital Advisors Portfolio holdings

AUM $1.47B
1-Year Est. Return 42.58%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+42.58%
3 Year Est. Return
+118.91%
5 Year Est. Return
10 Year Est. Return
AUM
$1.31B
AUM Growth
+$547M
Cap. Flow
+$550M
Cap. Flow %
41.91%
Top 10 Hldgs %
12.56%
Holding
778
New
34
Increased
551
Reduced
139
Closed
54

Top Buys

Rank Stock Value
1
CALY
Callaway Golf Company
CALY
+$8.8M
2
ST icon
Sensata Technologies
ST
+$7.69M
3
ECVT icon
Ecovyst
ECVT
+$6.89M
4
SNEX icon
StoneX
SNEX
+$6.6M
5
RDNT icon
RadNet
RDNT
+$6.55M

Sector Composition

Rank Sector Weight
1 Technology 25.16%
2 Healthcare 13.76%
3 Consumer Discretionary 12.73%
4 Industrials 12.73%
5 Financials 11.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNOW icon
351
Snowflake
SNOW
$116B
$1.02M 0.08%
7,531
+727
+11% +$107K
TKR icon
352
Timken Company
TKR
$8.91B
$1.01M 0.08%
12,617
+9,207
+270% +$794K
KNF icon
353
Knife River
KNF
$3.87B
$1.01M 0.08%
14,381
+10,886
+311% +$813K
HURN icon
354
Huron Consulting
HURN
$2.43B
$1.01M 0.08%
10,210
+2,927
+40% +$269K
CRDO icon
355
Credo Technology Group
CRDO
$46.2B
$1M 0.08%
31,383
+23,907
+320% +$529K
BIO icon
356
Bio-Rad Laboratories Class A
BIO
$9.53B
$1M 0.08%
3,663
+2,792
+321% +$812K
MSTR icon
357
Strategy Inc
MSTR
$37.8B
$999K 0.08%
7,250
+5,720
+374% +$824K
EW icon
358
Edwards Lifesciences
EW
$54B
$998K 0.08%
10,806
+14
+0.1% +$1.24K
CMPR icon
359
Cimpress
CMPR
$2.32B
$996K 0.08%
11,367
+2,725
+32% +$238K
FDS icon
360
Factset
FDS
$10.1B
$987K 0.08%
2,417
+1,203
+99% +$511K
ITCI
361
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$979K 0.07%
+14,298
New +$992K
SNPS icon
362
Synopsys
SNPS
$78.7B
$978K 0.07%
1,643
+4
+0.2% +$2.26K
EXC icon
363
Exelon
EXC
$46.2B
$973K 0.07%
28,118
-425
-1% -$15.7K
DPZ icon
364
Domino's
DPZ
$11.8B
$969K 0.07%
1,877
+1,399
+293% +$713K
CYTK icon
365
Cytokinetics
CYTK
$10.6B
$965K 0.07%
17,814
+14,270
+403% +$861K
AMN icon
366
AMN Healthcare
AMN
$1.28B
$962K 0.07%
18,776
+3,536
+23% +$200K
KMPR icon
367
Kemper
KMPR
$1.54B
$955K 0.07%
+16,102
New +$945K
ALTR
368
DELISTED
Altair Engineering Inc
ALTR
$955K 0.07%
9,738
+817
+9% +$71.9K
TNET icon
369
TriNet
TNET
$3.06B
$944K 0.07%
9,439
+6,933
+277% +$772K
XENE icon
370
Xenon Pharmaceuticals
XENE
$6.11B
$940K 0.07%
24,116
+20,891
+648% +$835K
CMI icon
371
Cummins
CMI
$87.1B
$935K 0.07%
3,377
-66
-2% -$18.9K
SPG icon
372
Simon Property Group
SPG
$71B
$935K 0.07%
6,161
+14
+0.2% +$2.06K
CASY icon
373
Casey's General Stores
CASY
$30.7B
$934K 0.07%
2,447
+1,638
+202% +$547K
LMAT icon
374
LeMaitre Vascular
LMAT
$1.89B
$929K 0.07%
11,296
+7,976
+240% +$586K
VMI icon
375
Valmont Industries
VMI
$9.52B
$929K 0.07%
3,386
+2,523
+292% +$615K

Similar funds

Harbor Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Harbor Capital Advisors held 778 positions worth $1.31B, up 71% from $765M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Harbor Capital Advisors deployed $550M of net new capital in Q2 2024, opening 34 new positions and adding to 551 existing holdings. Its largest new stake was NCR Voyix: 512,950 shares worth $6.33M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $3.32M trimmed.

  • Harbor Capital Advisors's largest Q2 2024 buy was NCR Voyix: 512,950 shares worth $6.33M.
  • Harbor Capital Advisors added most to Callaway Golf Company in Q2 2024, an estimated $8.8M increase.
  • Harbor Capital Advisors's biggest Q2 2024 reduction was Microsoft, cutting an estimated $3.32M.
  • Harbor Capital Advisors fully exited Autolus Therapeutics in Q2 2024, selling an estimated $1.78M.
  • Harbor Capital Advisors's ten largest holdings make up 13% of its $1.31B portfolio in Q2 2024.
  • Harbor Capital Advisors opened 34 new positions and closed 54 in Q2 2024.
  • Harbor Capital Advisors's portfolio value rose 71% quarter-over-quarter to $1.31B.

Based on Harbor Capital Advisors's 13F filing for Q2 2024, filed 9 Jul 2024.